KIT and leukemia: Using a combination of a mouse model of ETP-ALL and patient-derived xenografts, we identified leukemic cells co-expressing KIT and high levels of FLT3 (KF) that were most enriched for leukemia initiating activity, self-renewal, and chemoresistance.